ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (2023–2028)

Abstract:
Radiopharmaceuticals are emerging as next generation medical technologies for addressing complex health challenges, and their manufacture offers significant economic benefit to Australia. The ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) aims to establish a manufacturing platform for new medical technologies combining innovations in biotechnology and pharmaceutical science. The program addresses industry-led challenges for translation of biologics as molecular radiopharmaceuticals, building capacity in biomanufacturing, radiobiology and radiochemistry. The program establishes a dedicated manufacturing pipeline, future-proofing production and securing supply chain of next generation medical technologies.
Grant type:
ARC Industrial Transformation Research Hubs
Researchers:
  • Senior Group Leader and Deputy Dire
    Centre for Advanced Imaging
    Australian Institute for Bioengineering and Nanotechnology
    Affiliate PRF & Group Leader
    Australian Institute for Bioengineering and Nanotechnology
  • Industry Professor
    Australian Institute for Bioengineering and Nanotechnology
  • Principal Research Fellow and GL
    Australian Institute for Bioengineering and Nanotechnology
  • Principal Research Fellow - CAI
    Centre for Advanced Imaging
    Australian Institute for Bioengineering and Nanotechnology
  • Honorary Senior Res Fellow
    Mater Research Institute-UQ
    Faculty of Medicine
  • Head of Radiochemistry
    Centre for Advanced Imaging
    Australian Institute for Bioengineering and Nanotechnology
  • Postdoctoral Research Fellow
    Protein Expression Facility
  • Academic Director, Protein Expressi
    Protein Expression Facility
    Director, Protein Express Facility
    Australian Institute for Bioengineering and Nanotechnology
  • Professorial Research Fellow
    Faculty of Business, Economics and Law
Funded by:
Australian Research Council